286 related articles for article (PubMed ID: 11119570)
1. Dominance of virus over host factors in cross-species activation of human cytomegalovirus early gene expression.
García-Ramírez JJ; Ruchti F; Huang H; Simmen K; Angulo A; Ghazal P
J Virol; 2001 Jan; 75(1):26-35. PubMed ID: 11119570
[TBL] [Abstract][Full Text] [Related]
2. Multiple regulatory events influence human cytomegalovirus DNA polymerase (UL54) expression during viral infection.
Kerry JA; Priddy MA; Jervey TY; Kohler CP; Staley TL; Vanson CD; Jones TR; Iskenderian AC; Anders DG; Stenberg RM
J Virol; 1996 Jan; 70(1):373-82. PubMed ID: 8523551
[TBL] [Abstract][Full Text] [Related]
3. The role of ATF in regulating the human cytomegalovirus DNA polymerase (UL54) promoter during viral infection.
Kerry JA; Priddy MA; Staley TL; Jones TR; Stenberg RM
J Virol; 1997 Mar; 71(3):2120-6. PubMed ID: 9032345
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the human versus murine cytomegalovirus immediate early gene promoters for transgene expression by adenoviral vectors.
Addison CL; Hitt M; Kunsken D; Graham FL
J Gen Virol; 1997 Jul; 78 ( Pt 7)():1653-61. PubMed ID: 9225042
[TBL] [Abstract][Full Text] [Related]
5. Binding of SP1 to the immediate-early protein-responsive element of the human cytomegalovirus DNA polymerase promoter.
Luu P; Flores O
J Virol; 1997 Sep; 71(9):6683-91. PubMed ID: 9261391
[TBL] [Abstract][Full Text] [Related]
6. Identification of sequence elements in the human cytomegalovirus DNA polymerase gene promoter required for activation by viral gene products.
Kerry JA; Priddy MA; Stenberg RM
J Virol; 1994 Jul; 68(7):4167-76. PubMed ID: 8207792
[TBL] [Abstract][Full Text] [Related]
7. Two gamma interferon-activated site-like elements in the human cytomegalovirus major immediate-early promoter/enhancer are important for viral replication.
Netterwald J; Yang S; Wang W; Ghanny S; Cody M; Soteropoulos P; Tian B; Dunn W; Liu F; Zhu H
J Virol; 2005 Apr; 79(8):5035-46. PubMed ID: 15795289
[TBL] [Abstract][Full Text] [Related]
8. Regulatory Interaction between the Cellular Restriction Factor IFI16 and Viral pp65 (pUL83) Modulates Viral Gene Expression and IFI16 Protein Stability.
Biolatti M; Dell'Oste V; Pautasso S; von Einem J; Marschall M; Plachter B; Gariglio M; De Andrea M; Landolfo S
J Virol; 2016 Sep; 90(18):8238-50. PubMed ID: 27384655
[TBL] [Abstract][Full Text] [Related]
9. Transcription factor Sp1 mediates cell-specific trans-activation of the human cytomegalovirus DNA polymerase gene promoter by immediate-early protein IE86 in glioblastoma U373MG cells.
Wu J; O'Neill J; Barbosa MS
J Virol; 1998 Jan; 72(1):236-44. PubMed ID: 9420220
[TBL] [Abstract][Full Text] [Related]
10. Interferon-alpha inhibits the murine cytomegalovirus immediate-early gene expression by down-regulating NF-kappa B activity.
Gribaudo G; Ravaglia S; Gaboli M; Gariglio M; Cavallo R; Landolfo S
Virology; 1995 Aug; 211(1):251-60. PubMed ID: 7645218
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional regulation of the human cytomegalovirus US11 early gene.
Chau NH; Vanson CD; Kerry JA
J Virol; 1999 Feb; 73(2):863-70. PubMed ID: 9882286
[TBL] [Abstract][Full Text] [Related]
12. Characterization of drug resistance-associated mutations in the human cytomegalovirus DNA polymerase gene by using recombinant mutant viruses generated from overlapping DNA fragments.
Cihlar T; Fuller MD; Cherrington JM
J Virol; 1998 Jul; 72(7):5927-36. PubMed ID: 9621055
[TBL] [Abstract][Full Text] [Related]
13. Modulation of human cytomegalovirus immediate-early gene enhancer by mitogen-activated protein kinase kinase kinase-1.
Sun B; Harrowe G; Reinhard C; Yoshihara C; Chu K; Zhuo S
J Cell Biochem; 2001; 83(4):563-73. PubMed ID: 11746500
[TBL] [Abstract][Full Text] [Related]
14. Allitridin inhibits human cytomegalovirus replication in vitro.
Zhang J; Wang H; Xiang ZD; Shu SN; Fang F
Mol Med Rep; 2013 Apr; 7(4):1343-9. PubMed ID: 23426791
[TBL] [Abstract][Full Text] [Related]
15. RNA interference-mediated targeting of human cytomegalovirus immediate-early or early gene products inhibits viral replication with differential effects on cellular functions.
Xiaofei E; Stadler BM; Debatis M; Wang S; Lu S; Kowalik TF
J Virol; 2012 May; 86(10):5660-73. PubMed ID: 22438545
[TBL] [Abstract][Full Text] [Related]
16. Use of recombinant virus to assess human cytomegalovirus early and late promoters in the context of the viral genome.
Kohler CP; Kerry JA; Carter M; Muzithras VP; Jones TR; Stenberg RM
J Virol; 1994 Oct; 68(10):6589-97. PubMed ID: 8083994
[TBL] [Abstract][Full Text] [Related]
17. The human cytomegalovirus origin of DNA replication (oriLyt) is the critical cis-acting sequence regulating replication-dependent late induction of the viral 1.2-kilobase RNA promoter.
Wade EJ; Spector DH
J Virol; 1994 Oct; 68(10):6567-77. PubMed ID: 8083993
[TBL] [Abstract][Full Text] [Related]
18. Identification of newly detected, drug-related HCMV UL97- and UL54-mutations using a modified plaque reduction assay.
Fischer L; Sampaio KL; Jahn G; Hamprecht K; Göhring K
J Clin Virol; 2015 Aug; 69():150-5. PubMed ID: 26209398
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a thienylcarboxamide derivative that inhibits the transactivation functions of cytomegalovirus IE2 and varicella zoster virus IE62.
Majima R; Shindoh K; Yamaguchi T; Inoue N
Antiviral Res; 2017 Apr; 140():142-150. PubMed ID: 28161581
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of the human cytomegalovirus immediate-early region 2 gene that stimulates gene expression from an inducible promoter.
Hermiston TW; Malone CL; Witte PR; Stinski MF
J Virol; 1987 Oct; 61(10):3214-21. PubMed ID: 3041043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
